文献速递肾小球疾病

靶向WIP1磷酸酶促进实验性塌陷性肾小球病部分缓解

Targeting WIP1 phosphatase promotes partial remission in experimental collapsing glomerulopathy.
PubMed 文献 · Kidney Int · 2024-02-27

本研究在端粒酶诱导的塌陷性肾小球病(CG)小鼠模型(i-TERTci小鼠)和HIV相关肾病模型(Tg26小鼠)中,评估WIP1磷酸酶失活或药物抑制对疾病的作用。WIP1缺失阻断疾病起始,与衰老增强及TGF-β功能相关;药物抑制WIP1促进蛋白尿部分缓解并改善肾脏组织病理,且不促进纤维化或炎症。提示靶向WIP1可能是CG的有效治疗策略。

要点

  • WIP1缺失可阻断i-TERTci小鼠CG疾病起始,该过程需TGF-β功能并伴衰老增强。
  • 药物抑制WIP1在i-TERTci和Tg26小鼠中促进蛋白尿部分缓解并改善肾脏病理。
  • 选择性抑制WIP1不促进肾脏纤维化或炎症。

核心结论

  • 靶向WIP1可能是塌陷性肾小球病患者的有效治疗策略。

研究设计与样本

  • 使用端粒酶诱导的CG小鼠模型(i-TERTci小鼠)和HIVAN小鼠模型(Tg26小鼠)进行实验研究。

主要发现

  • WIP1失活阻断i-TERTci小鼠疾病起始,与衰老增强相关并需要TGF-β功能。
  • 药物抑制WIP1在i-TERTci和Tg26小鼠中促进蛋白尿部分缓解并改善肾脏组织病理特征。
  • 选择性抑制WIP1不促进肾脏纤维化或炎症。

关键数值与推荐

  • WIP1缺失阻断i-TERTci小鼠CG疾病起始。
  • 药物抑制WIP1在i-TERTci和Tg26小鼠中促进蛋白尿部分缓解并改善组织病理。
  • 选择性WIP1抑制不促进肾脏纤维化或炎症。

临床怎么用

  • 靶向WIP1可能作为塌陷性肾小球病的潜在治疗方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Collapsing focal segmental glomerulosclerosis (FSGS), also known as collapsing glomerulopathy (CG), is the most aggressive variant of FSGS and is characterized by a rapid progression to kidney failure. Understanding CG pathogenesis represents a key step for the development of targeted therapies. Previous work implicated the telomerase protein component TERT in CG pathogenesis, as transgenic TERT expression in adult mice resulted in a CG resembling that seen in human primary CG and HIV-associated nephropathy (HIVAN). Here, we used the telomerase-induced mouse model of CG (i-TERTci mice) to identify mechanisms to inhibit CG pathogenesis. Inactivation of WIP1 phosphatase, a p53 target acting in a negative feedback loop, blocked disease initiation in i-TERTci mice. Repression of disease initiation upon WIP1 deficiency was associated with senescence enhancement and required transforming growth factor-β functions. The efficacy of a pharmacologic treatment to reduce disease severity in both i-TERTci mice and in a mouse model of HIVAN (Tg26 mice) was then assessed. Pharmacologic inhibition of WIP1 enzymatic activity in either the telomerase mice with CG or in the Tg26 mice promoted partial remission of proteinuria and ameliorated kidney histopathologic features. Histological as well as high-throughput sequencing methods further showed that selective inhibition of WIP1 does not promote kidney fibrosis or inflammation. Thus, our findings suggest that targeting WIP1 may be an effective therapeutic strategy for patients with CG.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Duret LC, Hamidouche T, Steers NJ, et al. Targeting WIP1 phosphatase promotes partial remission in experimental collapsing glomerulopathy. Kidney Int. 2024. PMID: 38423182. doi:10.1016/j.kint.2024.02.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。